The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
No nobody cares Eva, I am embarrassed for you - You just posted "I am the chosen one" and were serious. I dont even think you realise how ridiculous you are when you are sober, let alone when you are on the red..
How did you manage to talk to them.. I have been on hold for 51mins so far and its ****ing me right off!
I cant get through to HL - I still have the money in my account for my open offer shares, but want to buy on the open market now. Are there any repercussions if I have said I want them and then dont have the funds available? Is it legally binding or anything?
I really don’t see why we are arguing about if it’s dilution or not. They have reduced their holding, fact. It’s possible they are part of the placing, I hope they are, but as of now they have reduced.
Will placing TR1s be this week or next? Looking forward to seeing who has committed to Synairgen
What an odd day, the most stable I have seen the price since I’ve been in (April).
https://www.pressreader.com/uk/daily-express/20201017/281655372553740
He’s a turd
Is this as per what's reported here? I hope this is accurate but as we know the reporting on what is a buy/sell here is not to be trusted.
It literally says in the post its only available to EU countries.
Cont:
Is it the intention to extend the MAP to outside of Europe?
Yes, every country has their own schemes. Some countries are easier to work with than others (according to Clinigen). If Clinigen want to talk to other KOLs in other countries then that is fine by us
If the MAP is extended to the USA, would you intend to do any direct to consumer advertising there?
We would be surprised if you were allowed to do that without a full approval
Have you completed all the scale up and validation work required for producing 100,000 treatments per month?
This work started back in April, we see it as low risk, so we are getting on with it and creating the reports, it is not completed, it all comes together at the end
If so, will the product from these batches be used for the initial MAP supplies?
Some of this material will be used for post approval supplies, MAP supplies will probably come from smaller scale batches. We will use what we can, we won’t be giving it away for free
What sort of regulatory approval will be required to commence the MAP in Europe, will it be done on a country by country basis in Europe, or will it be a centralised procedure?
Clinigen will manage the formal process when patients meet certain criteria.
Will you do any Interviews on the MAP announcement?
We won’t do any interviews on the MAPs or the interims. The next interviews are likely to be on feedback on Regulatory interactions, scale ups and possibly peer review publication, or whatever comes first.
Not sure if this has already been shared, but Timbo003 on the ADVFN guild had a phone call with Richard today and got a few questions answer. Below is a copy and paste:
My notes from the phone chat I had with RM earlier today, please note that it is not a verbatim account, but it is a probably a reasonable representation of what we discussed.
What are the most likely sources of funding for patients to access a course of SNG001, which based on comments in the most recent Finncap update is likely to be roughly the same cost as a course of Refib?
It could come from anywhere. This program is used when a Doctor is scratching their head on what to do, that’s when they contact Clinigen. We have had a lot of inbound request from physicians, but we haven’t been able to do anything about it. The Hospitals themselves often pay for the drugs from their own budgets, sometimes patients will pay themselves. Clinigen get a certain percentage of the sales. (Note: I also mentioned several time a £1000 – £2000 price in this part of the chat, Richard did not correct me on this)
KOLs around Europe will need to be made aware of the benefits of SNG001 in order for it to gain widespread usage in the MAP, the best way to do this is surely to get the proof of concept study published in a high impact Journal and follow up with a medical media blitz, can you give an update on progress on this front including target Journal and likely timing for publication?
Normally we would take a 6m to a year to get a peer review publication. This time it is not going to take that long, but it has only been a couple of months since we first broke cover with the preliminary data.
A lot of KOLs have heard of SNG001 and are already aware of the results and a lot of them have contacted us to have a relationship with the company. We cannot give an update on when it will be published, (I then suggested that the new clinical information in the RNS was a copy and paste from the draft manuscript, Richard replied that it was a good guess). A better way to answer the question was to confirm that the company was having a lot of chats with KOLs and regulators and disclosing information that we had not disclosed to investors and that didn’t seem right, so the clinical information in today’s RNS ensured that investors were bought up to speed on that new information. The other thing is that a lot of people seemed a bit confused as to how you can have a primary endpoint that can be analysed in different ways, well you can with a scale and you can interrogate it in different ways and all of those are the primary end points and it is nice to put it all in one place (i.e the RNS) and to also include the per protocol (PP) population, because people like that and they like it because the PP population took more drug and more drug equals quite a good effect ??
Can you provide a link showing we are now on the recovery trial? I missed it and can’t find any info
Well you know - I wouldn't want to be out of this over the weekend!!
I'm back in again after 48hr spending just as much time here without even being invested and still doing as much research. GLA!
Thanks all and I hope my post doesn't put anyone off - I still think Synairgen is going to make it and be approved. Its purely a personal decision as I have some life stresses at the moment and need to simplify my life for a while. I will check in with you all when you are popping champagne corks soon! GLA
I honestly wish you all the best, and I still likely think I have made a mistake - But I this share is stressing me too much on a daily basis. I've been in since April, so walking away with a nice profit after cashing in just over 28,000 shares. Now I have done that, you will get the RNS tomorrow lol. I've also sold the rest of my shares in other companies and am spending time away from stocks for a while! GLA and I hope this turns out as we have all hoped.
Not really showing any new information but didn’t see if posted already
https://www.proactiveinvestors.co.uk/pdf/create/news/details/219796/I
Speaking of Labour, has anyone asked them to push why SNG001 isn’t being fast tracked? Surely they would be keen to ask in the commons?
There is no timeline Ghia, confused people getting muddled up.